163 related articles for article (PubMed ID: 37821439)
1. USP39 promotes hepatocellular carcinogenesis through regulating alternative splicing in cooperation with SRSF6/HNRNPC.
Zheng J; Wu S; Tang M; Xi S; Wang Y; Ren J; Luo H; Hu P; Sun L; Du Y; Yang H; Wang F; Gao H; Dai Z; Ou X; Li Y
Cell Death Dis; 2023 Oct; 14(10):670. PubMed ID: 37821439
[TBL] [Abstract][Full Text] [Related]
2. The Deubiquitinase USP39 Promotes Esophageal Squamous Cell Carcinoma Malignancy as a Splicing Factor.
Zhu X; Ma J; Lu M; Liu Z; Sun Y; Chen H
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627203
[TBL] [Abstract][Full Text] [Related]
3. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo.
Yuan X; Sun X; Shi X; Jiang C; Yu D; Zhang W; Guan W; Zhou J; Wu Y; Qiu Y; Ding Y
Oncol Rep; 2015 Aug; 34(2):823-32. PubMed ID: 26081192
[TBL] [Abstract][Full Text] [Related]
4. Relative strength of 5' splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA.
Choi N; Liu Y; Oh J; Ha J; Ghigna C; Zheng X; Shen H
BMB Rep; 2021 Mar; 54(3):176-181. PubMed ID: 33050987
[TBL] [Abstract][Full Text] [Related]
5. USP39 stabilizes β-catenin by deubiquitination and suppressing E3 ligase TRIM26 pre-mRNA maturation to promote HCC progression.
Wang W; Lei Y; Zhang G; Li X; Yuan J; Li T; Zhong W; Zhang Y; Tan X; Song G
Cell Death Dis; 2023 Jan; 14(1):63. PubMed ID: 36707504
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase USP39 and E3 ligase TRIM26 balance the level of ZEB1 ubiquitination and thereby determine the progression of hepatocellular carcinoma.
Li X; Yuan J; Song C; Lei Y; Xu J; Zhang G; Wang W; Song G
Cell Death Differ; 2021 Aug; 28(8):2315-2332. PubMed ID: 33649471
[TBL] [Abstract][Full Text] [Related]
7. The spliceosome component Usp39 controls B cell development by regulating immunoglobulin gene rearrangement.
Ruan GX; Li Y; Chen W; Huang H; Zhang R; Chen C; Lam KP; Xu S; Ou X
Cell Rep; 2022 Feb; 38(6):110338. PubMed ID: 35139388
[TBL] [Abstract][Full Text] [Related]
8. USP39 promotes tumorigenesis by stabilizing and deubiquitinating SP1 protein in hepatocellular carcinoma.
Dong X; Liu Z; Zhang E; Zhang P; Wang Y; Hang J; Li Q
Cell Signal; 2021 Sep; 85():110068. PubMed ID: 34197957
[TBL] [Abstract][Full Text] [Related]
9. Splicing factor USP39 promotes ovarian cancer malignancy through maintaining efficient splicing of oncogenic HMGA2.
Wang S; Wang Z; Li J; Qin J; Song J; Li Y; Zhao L; Zhang X; Guo H; Shao C; Kong B; Liu Z
Cell Death Dis; 2021 Mar; 12(4):294. PubMed ID: 33731694
[TBL] [Abstract][Full Text] [Related]
10. USP39 Deubiquitinase Is Essential for
Fraile JM; Manchado E; Lujambio A; Quesada V; Campos-Iglesias D; Webb TR; Lowe SW; López-Otín C; Freije JM
J Biol Chem; 2017 Mar; 292(10):4164-4175. PubMed ID: 28154181
[No Abstract] [Full Text] [Related]
11. Spliceosome component Usp39 contributes to hepatic lipid homeostasis through the regulation of autophagy.
Cui D; Wang Z; Dang Q; Wang J; Qin J; Song J; Zhai X; Zhou Y; Zhao L; Lu G; Liu H; Liu G; Liu R; Shao C; Zhang X; Liu Z
Nat Commun; 2023 Nov; 14(1):7032. PubMed ID: 37923718
[TBL] [Abstract][Full Text] [Related]
12. HNRNPC impedes m
Huang XT; Li JH; Zhu XX; Huang CS; Gao ZX; Xu QC; Zhao W; Yin XY
Cancer Lett; 2021 Oct; 518():196-206. PubMed ID: 34271104
[TBL] [Abstract][Full Text] [Related]
13. Lentivirus mediated silencing of ubiquitin specific peptidase 39 inhibits cell proliferation of human hepatocellular carcinoma cells in vitro.
Pan Z; Pan H; Zhang J; Yang Y; Liu H; Yang Y; Huang G; Ni J; Huang J; Zhou W
Biol Res; 2015 Mar; 48(1):18. PubMed ID: 25889525
[TBL] [Abstract][Full Text] [Related]
14. Poison cassette exon splicing of SRSF6 regulates nuclear speckle dispersal and the response to hypoxia.
de Oliveira Freitas Machado C; Schafranek M; Brüggemann M; Hernández Cañás MC; Keller M; Di Liddo A; Brezski A; Blümel N; Arnold B; Bremm A; Wittig I; Jaé N; McNicoll F; Dimmeler S; Zarnack K; Müller-McNicoll M
Nucleic Acids Res; 2023 Jan; 51(2):870-890. PubMed ID: 36620874
[TBL] [Abstract][Full Text] [Related]
15. Identification of HnRNPC as a novel Tau exon 10 splicing factor using RNA antisense purification mass spectrometry.
Xing S; Wang J; Wu R; Hefti MM; Crary JF; Lu Y
RNA Biol; 2022; 19(1):104-116. PubMed ID: 34965173
[TBL] [Abstract][Full Text] [Related]
16. USP39 mediates p21-dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis.
Yuan J; Li X; Zhang G; Cheng W; Wang W; Lei Y; Ma Q; Song G
Mol Carcinog; 2021 Apr; 60(4):265-278. PubMed ID: 33634905
[TBL] [Abstract][Full Text] [Related]
17. RNA splicing factor USP39 promotes glioma progression by inducing TAZ mRNA maturation.
Ding K; Ji J; Zhang X; Huang B; Chen A; Zhang D; Li X; Wang X; Wang J
Oncogene; 2019 Sep; 38(37):6414-6428. PubMed ID: 31332287
[TBL] [Abstract][Full Text] [Related]
18. The RNA-binding profile of the splicing factor SRSF6 in immortalized human pancreatic β-cells.
Alvelos MI; Brüggemann M; Sutandy FR; Juan-Mateu J; Colli ML; Busch A; Lopes M; Castela Â; Aartsma-Rus A; König J; Zarnack K; Eizirik DL
Life Sci Alliance; 2021 Mar; 4(3):. PubMed ID: 33376132
[TBL] [Abstract][Full Text] [Related]
19. Prespliceosome structure provides insights into spliceosome assembly and regulation.
Plaschka C; Lin PC; Charenton C; Nagai K
Nature; 2018 Jul; 559(7714):419-422. PubMed ID: 29995849
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of USP39 induces cell cycle arrest and apoptosis in melanoma.
Zhao Y; Zhang B; Lei Y; Sun J; Zhang Y; Yang S; Zhang X
Tumour Biol; 2016 Oct; 37(10):13167-13176. PubMed ID: 27456357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
